The use of receiver operating characteristic analysis for detection of minimal residual disease using five-color multiparameter flow cytometry in acute myeloid leukemia identifies patients with high risk of relapse-Reference-Cited by-同舟云学术

The use of receiver operating characteristic analysis for detection of minimal residual disease using five-color multiparameter flow cytometry in acute myeloid leukemia identifies patients with high risk of relapse

Published:2009-03 Issue:2 Volume:76B Page:91-101
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Al-Mawali Adhra,Gillis David,Lewis Ian

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Reference32 articles.

1. Intensive postremission chemotherapy in adults with acute myeloid leukemia;Mayer;Cancer and leukemia Group B. N Engl J Med,1994

2. Detection of minimal residual disease in acute myelogenous leukemia;Raanani;Acta Haematol,2004

3. Minimal residual disease monitoring by flow cytometry;Vidriales;Best Pract Res Clin Haematol,2003

4. RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: Breakpoint cluster region and clinical implications;Schmidt;Leukemia,2004

5. Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia;Kern;Blood,2004

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of combined WT1 and multiparameter flow cytometry assessment for measurable residual disease after induction in non-APL acute myeloid leukemia;Scandinavian Journal of Clinical and Laboratory Investigation;2023-06-24

2. Flow Cytometric Techniques in the Diagnosis and Monitoring of Acute Leukaemias;Pathogenesis and Treatment of Leukemia;2023

3. Association of hematologic response and assay sensitivity on the prognostic impact of measurable residual disease in acute myeloid leukemia: a systematic review and meta-analysis;Leukemia;2022-10-19

4. Role of Minimal Residual Disease Testing in Acute Myeloid Leukemia;Clinics in Laboratory Medicine;2021-09

5. Measurable Residual Disease Detected by Multiparameter Flow Cytometry and Sequencing Improves Prediction of Relapse and Survival in Acute Myeloid Leukemia;Frontiers in Oncology;2021-05-20